相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients
Michele F. Eisenga et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During Renin-Angiotensin-Aldosterone System Blockade
Jelmer K. Humalda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Serum Phosphorus and Mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect Modification by Fasting
Alex R. Chang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction: The Alpha Omega Trial
Ellen K. Hoogeveen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients
L. C. Baia et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial
Ellen K. Hoogeveen et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
Leandro C. Baia et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Acute Effects of Very-Low-Protein Diet on FGF23 Levels: A Randomized Study
Biagio Di Iorio et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Fibroblast Growth Factor 23 and Inflammation in CKD
Fair Aunoz Mendoza et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients
Won Suk An et al.
NUTRITION RESEARCH (2012)
Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data
Sabita S. Soedamah-Muthu et al.
BMJ OPEN (2012)
The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB
Juan A. Moreno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
Martin H. de Borst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega Trial
Johanna M. Geleijnse et al.
AMERICAN HEART JOURNAL (2010)
First certified reference material for cystatin C in human serum ERM-DA471/IFCC
Anders Grubb et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Sarah Seiler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids
William S. Harris et al.
JOURNAL OF NUTRITION (2009)
Determination of fibroblast growth factor 23
Annemieke C. Heijboer et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Coronary calcium as a predictor of coronary events in four racial or ethnic groups
Robert Detrano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction -: A placebo-controlled randomized study
Trine Madsen et al.
EUROPEAN JOURNAL OF NUTRITION (2007)
Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values
Andrew S. Levey et al.
CLINICAL CHEMISTRY (2007)
N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: A randomized, placebo-controlled intervention trial
My Svensson et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity
M Taccone-Gallucci et al.
KIDNEY INTERNATIONAL (2006)
EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells:: Evidence for a PPAR-γ-dependent mechanism
H Li et al.
KIDNEY INTERNATIONAL (2005)
Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects
A Geelen et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2004)
Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse
T Shimada et al.
CIRCULATION (2004)
HMG-CoA reductase inhibitors up-regulate anti-aging klotho rnRNA via RhoA inactivation in IMCD3 cells
H Narumiya et al.
CARDIOVASCULAR RESEARCH (2004)
Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality
GM London et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein:: a dose-response study
T Madsen et al.
BRITISH JOURNAL OF NUTRITION (2003)
High stability of markers of cardiovascular risk in blood samples
EJ Giltay et al.
CLINICAL CHEMISTRY (2003)
Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors
RV Freeman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study
JC Longenecker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Statistics notes - Analysing controlled trials with baseline and follow up measurements
AJ Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
AK Cheung et al.
KIDNEY INTERNATIONAL (2000)
分享论文
